Women and Men: Sex Differences in Cardiovascular Risk Prevention
Abstract
Cardiovascular disease (CVD) is the leading cause of death in women, and knowledge of the clinical con¬sequences of atherosclerosis and CVD in women has grown tremendously over the past 20 years. Research efforts have increased and many reports on various aspects of ischaemic heart disease (IHD) in women have been published highlighting sex differences in pathophysiology, presentation, and treatment of IHD. For the past three decades, dramatic declines in heart disease mortality for both men and women have been observed, especially in the > 65 years' age group. But despite it according to the Global Burden of Disease, in 2004, CVD caused almost 32 % of deaths in women worldwide vs. 27 % in men. In Europe, 54 % of all females' death are from CVD vs. 43 % in men. Recent evidence has emerged that recognizes new, potentially independent, CVD risk factors exclusive to women. In particular, common disorders of pregnancy, such as gestational hypertension and diabetes, as well as frequently occurring endocrine disorders in women of reproductive age are associated with accelerated development of CVD and impaired CVD-free survival. With the recent availability of prospective studies comprising men and women, the equivalency of major risk factors prevalence and effects on CVD between men and women can be examined. Furthermore, female-specific risk factors might be identified enabling early detection of apparently healthy women with a high lifetime risk of CVD. Therefore, we examined the available literature regarding the prevalence and effects of the traditional major risk factors for CVD in men and women.
About the Authors
T. Kikalishvili
Emergency Cardiology Center by Acad. G. Chapidze
Georgia
Georgia
V. Chumburidze
Emergency Cardiology Center by Acad. G. Chapidze
Georgia
Georgia
References
1. Mozaffarian D., Benjamin E.J., Go A.S., Arnett D.K., Blaha M.J., Cushman M., de Ferranti S., Després J.P., Fullerton H.J., Howard V.J., Huffman M.D., Judd S.E., Kissela B.M., Lackland D.T., Lichtman J.H., Lisabeth L.D., Liu S., Mackey R.H., Matchar D.B., McGuire D.K., Mohler .ER.3rd, Moy C.S., Muntner P., Mussolino M.E., Nasir K., Neumar R.W., Nichol G., Palaniappan L., Pandey D.K., Reeves M.J., Rodriguez C.J., Sorlie P.D., Stein J., Towfighi A., Turan T.N., Virani S.S., Willey J.Z., Woo D., Yeh R.W., Turner M.B. Heart disease and stroke statistics – 2015 update: a report from the American Heart Association. Circulation, 2015, vol. 131, no. 4, e29-322. doi: 10.1161/CIR.0000000000000152. Epub 2014 Dec 17.
2. Wilmot K.A., O’Flaherty M., Capewell S., Ford E.S., Vaccarino V. Coronary Heart Disease Mortality Declines in the United States From 1979 Through 2011: Evidence for Stagnation in Young Adults, Especially Women. Circulation, 2015, vol. 132, no. 11, pp. 997-1002.
3. Center for Disease Control and Prevention. National Diabetes Statistics Report. Estimates of Diabetes and Its Burden in the United States, 2014. Atlanta : US Department of Health and Human Services, 2014.
4. Pomp E.R., Rosendaal F.R., Doggen C.J. Smoking increases the risk of venous thrombosis and acts synergistically with oral contraceptive use. Am J Hematol, 2008, vol. 83, no. 2, pp. 97-102.
5. Wilson P.W, D’Agostino R.B., Sullivan L., Parise H., Kannel W.B. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med, 2002, vol. 162, no. 16, pp. 1867-1872.
6. Safford M.M., Gamboa C.M., Durant R.W., Brown T.M., Glasser S.P., Shikany J.M., Zweifler R.M., Howard G., Muntner P. Race-sex differences in the management of hyperlipidemia: the REasons for Geographic and Racial Differences in Stroke study. Am J Prev Med, 2015, vol. 48, no. 5, pp. 520-527. doi: 10.1016/j.amepre.2014.10.025.
7. Linné Y., Dye L., Barkeling B., Rössner S. Long-term weight development in women: a 15-year follow-up of the effects of pregnancy. Obes Res, 2004, vol. 12, no. 7, pp. 1166-1178.
8. del Rincón I., Polak J.F., O’Leary D.H., Battafarano D.F., Erikson J.M., Restrepo J.F., Molina E., Escalante A. Systemic inflammation and cardiovascular risk factors predict rapid progression of atherosclerosis in rheumatoid arthritis. Ann Rheum Dis, 2015, vol. 74, no. 6, pp. 1118-1123.
9. Peters M.J., Symmons D.P., McCarey D., Dijkmans B.A., Nicola P., Kvien T.K., McInnes I.B., Haentzschel H., Gonzalez-Gay M.A., Provan S., Semb A., Sidiropoulos P., Kitas G., Smulders Y.M., Soubrier M., Szekanecz Z., Sattar N., Nurmohamed M.T. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis, 2010, vol. 69, no. 2, pp. 325-331.
10. Garcia M., Mulvagh S.L., Merz C.N., Buring J.E., Manson J.E. Cardiovascular Disease in Women: Clinical Perspectives. Circ Res, 2016, vol. 118, no. 8, pp. 1273-1293.
11. Brewer L.C., Svatikova A., Mulvagh S.L. The Challenges of Prevention, Diagnosis and Treatment of Ischemic Heart Disease in Women. Cardiovasc Drugs Ther, 2015, vol. 29, no. 4, pp. 355-368.
12. Galiuto L., Locorotondo G. Gender differences in cardiovascular disease. J Integr Cardiol, 2015, vol. 1, no. 1. doi: 10.15761 /JIC. 1000107.
13. Vaccarino V., Badimon L., Corti R., de Wit C., Dorobantu M., Hall A., Koller A., Marzilli M., Pries A., Bugiardini R. Ischaemic heart disease in women: are there sex differences in pathophysiology and risk factors?: Position Paper from the Working Group on Coronary Pathophysiology and Microcirculation of the European Society of Cardiology. Cardiovasc Res, 2011, vol. 90, no. 1, pp. 9-17.
14. Institute of Medicine's (IOM). Women's Health Research: Progress, Pitfalls, and Promise. Washington DC : National Academies Press, 2010, 438 p.
Review
For citations:
Kikalishvili T., Chumburidze V. Women and Men: Sex Differences in Cardiovascular Risk Prevention. Emergency Cardiology and Cardiovascular Risks journal. 2018;2(1):258-269.
Views:
16
Email this article 